NCT04477382View on ClinicalTrials.gov

Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Dust Mite AllergyAllergic Rhinitis
Interventions
DIETARY_SUPPLEMENT

holo-BLG (beta-lactoglobulin) - a major component of the protein fraction of raw milk, is loaded with ligands such as retinoic acid, zinc and polyphenol-iron complexes.

Subjects suffering from house dust mite (HDM) allergic rhinoconjunctivitis who are reacting positively to chamber exposure with HDM are reevaluated in the exposure chamber 3 months after taking food supplements.

Trial Locations (1)

10115

ECARF Institute GmbH, Berlin

All Listed Sponsors
collaborator

Bencard Allergie GmbH

OTHER

lead

Ecarf Institute GmbH

OTHER

NCT04477382 - Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis | Biotech Hunter | Biotech Hunter